CN1322000C - 果糖-1,6-二磷酸及其制备方法和用途 - Google Patents
果糖-1,6-二磷酸及其制备方法和用途 Download PDFInfo
- Publication number
- CN1322000C CN1322000C CNB031007244A CN03100724A CN1322000C CN 1322000 C CN1322000 C CN 1322000C CN B031007244 A CNB031007244 A CN B031007244A CN 03100724 A CN03100724 A CN 03100724A CN 1322000 C CN1322000 C CN 1322000C
- Authority
- CN
- China
- Prior art keywords
- fructose
- solution
- diphosphate
- yeast
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 23
- 239000002253 acid Substances 0.000 title description 4
- 229930091371 Fructose Natural products 0.000 claims abstract description 93
- 239000005715 Fructose Substances 0.000 claims abstract description 93
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 92
- 238000000034 method Methods 0.000 claims abstract description 76
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 72
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 claims description 72
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 claims description 69
- 239000011347 resin Substances 0.000 claims description 41
- 229920005989 resin Polymers 0.000 claims description 41
- 229920002472 Starch Polymers 0.000 claims description 29
- 239000008107 starch Substances 0.000 claims description 29
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 28
- 230000008569 process Effects 0.000 claims description 28
- 235000019698 starch Nutrition 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 24
- 239000008103 glucose Substances 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 19
- 241000894006 Bacteria Species 0.000 claims description 15
- 240000008042 Zea mays Species 0.000 claims description 14
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 14
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 12
- 238000010521 absorption reaction Methods 0.000 claims description 11
- 239000012535 impurity Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 10
- 229910019142 PO4 Inorganic materials 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 10
- 239000010452 phosphate Substances 0.000 claims description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 9
- 235000005822 corn Nutrition 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 108090000769 Isomerases Proteins 0.000 claims description 8
- 102000004195 Isomerases Human genes 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 claims description 8
- 230000008025 crystallization Effects 0.000 claims description 8
- 238000006317 isomerization reaction Methods 0.000 claims description 7
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 230000001186 cumulative effect Effects 0.000 claims description 4
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims description 4
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 240000005979 Hordeum vulgare Species 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 3
- 240000003183 Manihot esculenta Species 0.000 claims description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 3
- 241000209140 Triticum Species 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 159000000003 magnesium salts Chemical class 0.000 claims description 3
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 2
- 235000019800 disodium phosphate Nutrition 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 229940045641 monobasic sodium phosphate Drugs 0.000 claims description 2
- 238000004062 sedimentation Methods 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 102000012195 Fructose-1,6-bisphosphatases Human genes 0.000 abstract 4
- 108010017464 Fructose-Bisphosphatase Proteins 0.000 abstract 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 58
- 239000000243 solution Substances 0.000 description 34
- 239000007788 liquid Substances 0.000 description 25
- 239000000047 product Substances 0.000 description 20
- 239000002994 raw material Substances 0.000 description 19
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 18
- 238000005516 engineering process Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 14
- 235000021433 fructose syrup Nutrition 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 12
- 238000005342 ion exchange Methods 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- -1 phosphate radical Chemical class 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 6
- 244000285963 Kluyveromyces fragilis Species 0.000 description 6
- 108700040099 Xylose isomerases Proteins 0.000 description 6
- 239000003456 ion exchange resin Substances 0.000 description 6
- 229920003303 ion-exchange polymer Polymers 0.000 description 6
- 238000010899 nucleation Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 235000009973 maize Nutrition 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000010010 raising Methods 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- XPYBSIWDXQFNMH-UHFFFAOYSA-N D-fructose 1,6-bisphosphate Natural products OP(=O)(O)OCC(O)C(O)C(O)C(=O)COP(O)(O)=O XPYBSIWDXQFNMH-UHFFFAOYSA-N 0.000 description 3
- 206010019280 Heart failures Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000031018 biological processes and functions Effects 0.000 description 3
- 230000003570 biosynthesizing effect Effects 0.000 description 3
- 230000006567 cellular energy metabolism Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- RNBGYGVWRKECFJ-UHFFFAOYSA-N fructose-1,6-phosphate Natural products OC1C(O)C(O)(COP(O)(O)=O)OC1COP(O)(O)=O RNBGYGVWRKECFJ-UHFFFAOYSA-N 0.000 description 3
- 229910017053 inorganic salt Inorganic materials 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000222178 Candida tropicalis Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 241000235649 Kluyveromyces Species 0.000 description 2
- 241001138401 Kluyveromyces lactis Species 0.000 description 2
- 241000235395 Mucor Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- 229920002494 Zein Polymers 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 239000013070 direct material Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 150000002500 ions Chemical group 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 150000003016 phosphoric acids Chemical class 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 235000011008 sodium phosphates Nutrition 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 238000001238 wet grinding Methods 0.000 description 2
- 239000005019 zein Substances 0.000 description 2
- 229940093612 zein Drugs 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 208000006893 Fetal Hypoxia Diseases 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 206010028916 Neologism Diseases 0.000 description 1
- 102000001105 Phosphofructokinases Human genes 0.000 description 1
- 108010069341 Phosphofructokinases Proteins 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 244000046109 Sorghum vulgare var. nervosum Species 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- XMXOIHIZTOVVFB-JIZZDEOASA-L disodium;(2s)-2-aminobutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CC([O-])=O XMXOIHIZTOVVFB-JIZZDEOASA-L 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000020245 plant milk Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031007244A CN1322000C (zh) | 2003-01-20 | 2003-01-20 | 果糖-1,6-二磷酸及其制备方法和用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031007244A CN1322000C (zh) | 2003-01-20 | 2003-01-20 | 果糖-1,6-二磷酸及其制备方法和用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1519245A CN1519245A (zh) | 2004-08-11 |
| CN1322000C true CN1322000C (zh) | 2007-06-20 |
Family
ID=34281283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031007244A Expired - Fee Related CN1322000C (zh) | 2003-01-20 | 2003-01-20 | 果糖-1,6-二磷酸及其制备方法和用途 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1322000C (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100395252C (zh) * | 2006-06-12 | 2008-06-18 | 南京工业大学 | 一种连续分离1,6-二磷酸果糖的方法 |
| CN101904856A (zh) * | 2010-08-06 | 2010-12-08 | 南京南农高科兽药研究所有限公司 | 1,6-二磷酸果糖及其衍生物在制备动物医疗保健品中的应用 |
| CN109970825A (zh) * | 2019-03-21 | 2019-07-05 | 张家港市华天药业有限公司 | 一种制备果糖二磷酸镁的方法 |
| CN109836464B (zh) * | 2019-03-21 | 2021-02-19 | 张家港市华天药业有限公司 | 一种果糖二磷酸钙的制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4613678Y1 (zh) * | 1967-11-30 | 1971-05-14 | ||
| US5094947A (en) * | 1989-03-03 | 1992-03-10 | Unitika, Ltd. | Process for producing fructose-1,6-diphosphate |
| CN1089654A (zh) * | 1993-01-11 | 1994-07-20 | 欧阳平凯 | 1,6-二磷酸果糖的生产方法 |
| CN1041327C (zh) * | 1993-01-12 | 1998-12-23 | 中国人民解放军海军医学研究所 | 果糖二磷酸钠发酵生产方法 |
| CN1042953C (zh) * | 1995-07-10 | 1999-04-14 | 暨南大学 | 二磷酸果糖镁的制备方法 |
-
2003
- 2003-01-20 CN CNB031007244A patent/CN1322000C/zh not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4613678Y1 (zh) * | 1967-11-30 | 1971-05-14 | ||
| US5094947A (en) * | 1989-03-03 | 1992-03-10 | Unitika, Ltd. | Process for producing fructose-1,6-diphosphate |
| CN1089654A (zh) * | 1993-01-11 | 1994-07-20 | 欧阳平凯 | 1,6-二磷酸果糖的生产方法 |
| CN1041327C (zh) * | 1993-01-12 | 1998-12-23 | 中国人民解放军海军医学研究所 | 果糖二磷酸钠发酵生产方法 |
| CN1042953C (zh) * | 1995-07-10 | 1999-04-14 | 暨南大学 | 二磷酸果糖镁的制备方法 |
Non-Patent Citations (4)
| Title |
|---|
| 1,6-二磷酸果糖的制备和应用 张宏兴等,中国医药工业杂志,第26卷第3期 1995 * |
| 发酵法生产果糖1,6-二磷酸钠盐 许兆龙等,上海大学学报(自然科学版),第3卷第3期 1997 * |
| 固定化酵母细胞生产1,6-二磷酸果糖研究 孙志浩等,工业微生物,第26卷第2期 1996 * |
| 酶工程制备1,6-二磷酸果糖的中试研究 王丁刚等,药物生物技术,第3卷第1期 1996 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1519245A (zh) | 2004-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101451096B (zh) | 蛹虫草保健酒的制备方法 | |
| CN104013657B (zh) | 一种西洋参药材提取皂苷后微生物发酵再提取方法 | |
| CN104086305B (zh) | 一种蛹虫草子实体培养基 | |
| CN110055296B (zh) | 赖氨酸的制备方法及其应用 | |
| CN106148445A (zh) | 一种新的谷氨酸提取工艺 | |
| CN101555503A (zh) | 一种从生产木糖的废木糖母液中分离提取l-阿拉伯糖的方法 | |
| Roukas | Continuous ethanol production from carob pod extract by immobilized Saccharomyces cerevisiae in a packed‐bed reactor | |
| CN113498834A (zh) | 一种食药用菌发酵饮品的集成发酵的方法 | |
| CN108977388A (zh) | 一种富硒纳豆芽孢杆菌的生产方法及其所用培养基 | |
| CN1322000C (zh) | 果糖-1,6-二磷酸及其制备方法和用途 | |
| CN106085713A (zh) | 一种双菌种共固定化发酵桑果酒及其制备方法 | |
| CN101760489B (zh) | 一种用于生产咪唑立宾的发酵培养基 | |
| CN101250558B (zh) | 用石蒜属植物生产燃料乙醇的方法 | |
| CN104059857A (zh) | 一株曲霉及其在制备果糖基转移酶中的应用 | |
| CN103131643A (zh) | 一株产甘露醇的菌株及用该菌株发酵生产甘露醇的方法 | |
| CN108203693A (zh) | 利用烟草废弃物生产高浓度l-型乳酸的方法 | |
| CN101265453A (zh) | 一种含cmp激酶和cdp激酶的啤酒酵母菌的筛选及应用 | |
| JPS60244294A (ja) | セルロ−スから高濃度アルコ−ルを半連続的に製造する方法 | |
| CN110241030A (zh) | 一种灵芝菌丝体的培养方法及其应用 | |
| CN102628021B (zh) | 一种核桃苦荞酒及其酿造方法 | |
| CN109644778A (zh) | 一种食用菌液体发酵培养基及其制备方法 | |
| CN108796027A (zh) | 一种生产类胡萝卜素的方法 | |
| CN101914591A (zh) | 一种热带假丝酵母制备木糖醇的用途与高纯度木糖醇产物的制药、保健用途 | |
| CN1077417C (zh) | 根除黄曲霉毒素的低钠补碘保健酱油精的酿造方法 | |
| CN107164282B (zh) | 一种生产5‑羟色氨酸的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: XINGTAI PING'AN SUGAR INDUSTRY CO., LTD. Free format text: FORMER OWNER: ZHAO JIANAN Effective date: 20090612 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090612 Address after: West Industrial Zone, New River County, Hebei Province, China: 055650 Patentee after: Xingtai Pingan Sugar Co. Ltd. Address before: 147, Nei Nan Street, New River County, Hebei Province, zip code: 055650 Co-patentee before: Fu Haifeng Patentee before: Zhao Jian an |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070620 Termination date: 20180120 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |